A kinder, more thoughtful workplace can lead to better heart health among older employees, a new study finds. Older workers’ heart health risk factors decreased significantly when their office employed interventions designed to reduce work-family conflicts, researchers report in the Nov. 8 issue of the American Journal of Public Health. Specifically, their heart risk factors… read on > read on >
THURSDAY, Nov. 9, 2023 (HealthDay) — There’s good news for people with diabetes who are turning to drugs like Ozempic and Wegovy to treat their disease and lose weight: The drugs probably will not harm their vision. Semaglutide (the generic name for both medicines) can trigger rapid drops in blood sugar. Prior research had linked… read on > read on >
Strokes can strike anyone, but income and education may play a role in whether your stroke is fatal or disabling, new research shows. As reported Nov. 8 in the journal Neurology, folks who’d had a stroke were 10% more likely to die or become dependent on someone for their care if they were low-income or… read on > read on >
The best way to prevent cervical cancer in women is to give HPV vaccines to both boys and girls, a new study argues. That way, herd immunity could help eradicate the cancer-causing virus, researchers say. Cancer-related HPV strains declined significantly in Finnish towns where boys and girls both received the vaccine, according to findings published… read on > read on >
Eczema can be a burden on the mind as well the body, a new survey shows. People with eczema are more likely to experience depression and anxiety, and it worsens when additional allergic symptoms occur, according to a study to be presented Thursday at the American College of Allergy, Asthma and Immunology (ACAAI) annual meeting… read on > read on >
A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro. Both medications are made by Eli Lilly and Co. “Obesity and overweight are serious conditions that… read on > read on >
WEDNESDAY, Nov. 8, 2023 (Healthday News) — A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients won’t be able to afford the medication. Zurzuvae (zuranolone) was first approved by the U.S. Food and Drug Administration back in August,… read on > read on >
“Davey” Bauer hovered on the precipice of death, his lungs damaged by vaping and congested by antibiotic-resistant pneumonia. Doctors saved his life with a jury-rigged artificial lung, a prompt double-lung transplant… and a set of DD breast implants. Doctors at Northwestern Medicine crafted an artificial lung to keep Bauer, 34, alive after removing lungs so… read on > read on >
Black and Hispanic Americans might be receiving worse hospital care following cardiac arrest than Whites do, a new study reports. Only about 20% of Blacks and 22% of Hispanics admitted to a hospital after initially surviving cardiac arrest had a positive outcome, researchers found. The rest either died or suffered brain damage. By comparison, nearly… read on > read on >
Everyone knows smoking to be a major cause of cancer. Now, exactly how tobacco smoke triggers tumor development just got a bit clearer, thanks to new Canadian research. According to a team at the Ontario Institute for Cancer Research (OICR) in Toronto, smoking appears to prevent the formation of proteins that work to keep runaway… read on > read on >
